Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Extremity soft tissue sarcoma: controversial management issues.

Vijay P Khatri1, James E Goodnight

  • 1Division of Surgical Oncology, University of California, Davis, 4501 X Street, Suite 3010, Sacramento, CA 95817, USA.

Surgical Oncology
|March 22, 2005
PubMed
Summary

This review addresses key management questions for rare soft tissue sarcomas (STS) due to a lack of large trials. It examines biopsy impact, surgical margins, and adjuvant therapies for improved patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Growth of surgical oncology: A shared achievement.

Surgical oncology·2026
Same author

A platform for sharing current research and advancing patient care.

Surgical oncology·2025
Same author

Introduction to "Legends in oncology: Expert commentary".

Surgical oncology·2024
Same author

Editorial: Advances in treatment of colorectal cancer.

Surgical oncology·2022
Same author

Editorial.

Surgical oncology·2020
Same author

Precision Medicine in Colorectal Surgery.

Surgical oncology clinics of North America·2019

Area of Science:

  • Oncology
  • Surgical Pathology
  • Radiology

Background:

  • Soft tissue sarcomas (STS) are rare malignancies, limiting large-scale prospective randomized trials for treatment evaluation.
  • Clinical management decisions for STS often rely on single-institution experiences due to the scarcity of evidence-based guidelines.
  • Numerous controversies persist regarding optimal diagnostic and therapeutic strategies in STS management.

Purpose of the Study:

  • To review and address critical, unresolved clinical questions in the management of soft tissue sarcomas.
  • To synthesize current evidence and expert opinion on controversial aspects of STS diagnosis and treatment.
  • To provide guidance for clinicians facing complex management decisions in STS.

Main Methods:

  • Literature review and synthesis of existing data on key management issues in soft tissue sarcomas.

Related Experiment Videos

  • Discussion of controversies including biopsy quality, surgical approach, imaging, and adjuvant therapies.
  • Analysis of factors influencing local control and survival in STS patients.

    • Main Results:

    • The review will address the impact of biopsy quality on STS outcomes.
    • It will evaluate the necessity of re-excision after unplanned excisions.
    • The role of MRI, pre- vs. post-operative radiation, surgical margins, and adjuvant therapies (radiation and chemotherapy) will be discussed in relation to local control and survival.

    Conclusions:

    • Evidence-based answers are needed for critical STS management questions.
    • Optimizing surgical techniques, radiation timing, and adjuvant treatments may improve outcomes.
    • Further research is warranted to resolve ongoing controversies in STS care.